Genomics in Scotland strategy: business and regulatory impact assessment
Business and regulatory impact assessment (BRIA) for the Genomics in Scotland: Building our Future five-year national strategy (2024 to 2029).
15. Declaration and Publication
I have read the Business and Regulatory Impact Assessment, and I am satisfied that (a) it represents a fair and reasonable view of the expected costs, benefits and impact of the policy, and (b) that the benefits justify the costs. I am satisfied that business impact has been assessed with the support of businesses in Scotland.
Signed:
Date:
Minister’s name: Neil Gray
Minister’s title: Cabinet Secretary for NHS Recovery, Health and Social Care
Scottish Government Contact point: holly.ennis@gov.scot
Contact
Email: holly.ennis@gov.scot
There is a problem
Thanks for your feedback